Ajanta Pharma promoter pledges shares for new loan
Aayush Agrawal, a promoter of Ajanta Pharma, pledged 11,11,111 shares to RBL Bank Ltd for a new loan. The total encumbered shares for the Aayush Agrawal Trust increased to 1,25,56,198, or 10.05% of the company's share capital. The disclosure was made to comply with SEBI (SAST) Regulations, 2011.
*this image is generated using AI for illustrative purposes only.
Aayush Agrawal, a promoter of Ajanta Pharma , has created a pledge on 11,11,111 shares to secure a new loan, according to a regulatory filing submitted on June 12, 2026. The shares were pledged in favor of RBL Bank Ltd. The disclosure was made in compliance with Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
The filing details the shareholding and encumbrance status of various promoter entities. Aayush Agrawal, as trustee of the Aayush Agrawal Trust, holds a total of 1,41,12,924 shares, accounting for 11.30% of the company. Following the pledge creation on June 10, 2026, the total encumbered holding for this entity stands at 1,25,56,198 shares, representing 10.05% of the total share capital.
The transaction involved two separate pledge creations on the same date. The first pledge covered 8,92,860 shares, and the second covered 2,18,251 shares. Both were created for the purpose of a new loan.
Other promoter entities listed in the disclosure include Gabs Investments Pvt Ltd, which holds 27,70,000 encumbered shares, and trusts associated with key individuals such as Yogesh M Agrawal, Rajesh M Agrawal, and Ravi P Agrawal. While some entities hold existing encumbered shares, the recent pledge activity is specific to Aayush Agrawal as trustee of the Aayush Agrawal Trust.
The following table summarizes the shareholding and encumbrance details disclosed by the promoters:
| Name of the promoter(s) or PACs | Promoter holding (Number) | Promoter holding (%) | Promoter holding already encumbered (Number) | Promoter holding already encumbered (%) | Post event holding of encumbered shares (Number) | Post event holding of encumbered shares (%) |
|---|---|---|---|---|---|---|
| Gabs Investments Pvt Ltd | 1,25,88,393 | 10.08 | 27,70,000 | 2.22 | 27,70,000 | 2.22 |
| Yogesh M Agrawal, trustee Yogesh Agrawal Trust | 1,80,78,147 | 14.47 | - | - | - | - |
| Mannalal B Agrawal | 0 | 0.00 | - | - | - | - |
| Rajesh M Agrawal, trustee Rajesh Agrawal Trust | 1,80,78,148 | 14.47 | - | - | - | - |
| Ravi P Agrawal, trustee Ravi Agrawal Trust | 1,27,92,904 | 10.24 | 57,56,777 | 4.61 | 57,56,777 | 4.61 |
| Ravi P. Agrawal | 2,85,000 | 0.23 | - | - | - | - |
| Aayush M Agrawal, trustee Aayush Agrawal Trust | 1,41,12,924 | 11.30 | 1,23,37,947 | 9.88 | 1,25,56,198 | 10.05 |
| Aayush M. Agrawal | 30,000 | 0.02 | - | - | - | - |
| Ganga Exports represented by its partners Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal | 33,48,261 | 2.68 | - | - | - | - |
The document was signed by Aayush Agrawal, Trustee of the Aayush Agrawal Trust, and addressed to BSE Limited and the National Stock Exchange of India.
Historical Stock Returns for Ajanta Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.20% | +5.02% | +14.29% | +22.76% | +30.05% | +133.69% |
What is the specific purpose of the new loan secured by Aayush Agrawal, and will it be utilized for personal needs or corporate expansion?
How will the increased pledge level, now covering nearly 89% of Aayush Agrawal's trust holdings, impact investor confidence in Ajanta Pharma's governance?
Does this high level of encumbrance increase the risk of a margin call triggering a sell-off in the event of a market downturn?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
